MMRF PRESS RELEASES
President Bush Names Founder of Multiple Myeloma Research Foundation to National Cancer Advisory Board
June 22, 2004
President George W. Bush has announced his intention to appoint Kathryn Giusti, President and Founder of the New Canaan-based Multiple Myeloma Research Foundation, to a six-year term of the National Cancer Advisory Board. Ms. Giusti, who was one of five Board appointments the President made this week, will serve as a Board member until March 9, 2010.
The National Cancer Advisory Board (NCAB) advises the Secretary, Department of Health and Human Services, and the Director of the National Cancer Institute, with respect to the activities of the Institute. As an NCAB Board member, Ms. Giusti will help evaluate policy efforts to combat cancer at the national level, as well as offer recommendations on strategic collaborations, research and education.
"The NCAB is so crucial in the fight against cancer and ultimately in helping us to improve outcomes in all forms of cancer," said Ms. Giusti. "I feel privileged to be appointed by President Bush to work with such a distinguished group of professionals and use my own experience as a cancer patient and a leader of a research foundation to support such an integral force in cancer research as the NCAB in its mission to find a cure."
Ms. Giusti founded the Multiple Myeloma Research Foundation (MMRF) with her twin sister Karen Andrews in 1998, two years after she was diagnosed with the disease. Ms. Giusti brings a background in pharmaceutical marketing to the MMRF having started her career at Merck and later serving as the executive director of Searle's worldwide arthritis franchise and Midwest operations.
In addition to her appointment to the NCAB Board, Ms. Giusti also serves on the National Cancer Policy Board, the National Cancer Institute's Director's Consumer Liaison Group and is a member of the Cancer Leadership Council. She is also a member of the Board of Directors for IMS Health.
Ms. Giusti received her Masters in Business Administration from Harvard Business School and her undergraduate from the University of Vermont, where she graduated magna cum laude with a Bachelor of Science degree in Biological Science. She has been the recipient of several awards including the Healthcare Businesswoman's Association Woman of the Year, the Harvard Business School Entrepreneurial Award, the McCarty Cancer Foundation Humanitarian Award and the Joseph Michaeli Award from the Weill Medical College of Cornell University.
The MMRF is the number-one private funder of myeloma-specific research, raising more than $50 million to fund 49 institutions worldwide. The MMRF is the world's only non-profit organization to have the earned a four-star rating from Charity Navigator, approval by the Better Business Bureau's Wise Giving Alliance Standards for Charity Accountability, and approval by the National Cancer Institute for its grants-making process. To learn more about the MMRF, visit www.themmrf.org.
For information, contact:
Anne Quinn Young, MMRF, 203-652-0212, email@example.com